ACCESS Newswire
20 Oct 2021, 17:19 GMT+10
Emerging Sexual Health and Wellness Company Announces Development of Muco-Adhesive Strip Technology for the Delivery of Psilocybin
VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / LOVE Pharma Co. (CSE:LUV)(FSE:G1Q0), the Company has announced that it is developing a muco-adhesive sublingual strip. The Company is partnering with the strip's creator, a US based pharmaceutical company, to develop it for use as a psilocybin delivery system.
As psilocybin (the psychoactive chemical in so-called 'magic mushrooms')-having gained increased legitimacy in the mental healthcare field, following a 2018 'breakthrough' designation by the FDA, thereby allowing for the fast-tracking of drug trials-has become the lynchpin of an emerging health and wellness market; ensuring the safety of users through reliable systems of accurate dosing remains of paramount importance. Difficult to achieve with botanicals, pioneering companies including LOVE Pharma are developing new extracted products designed to deliver the most consistently accurate dosing possible. LOVE Pharma has acquired the rights for a muco-adhesive sublingual strip that it is currently developing for use with psilocybin.
Prominent medical institutions and research facilities in the UK and US have been conducting studies and trials to determine the efficacy of psilocybin in treating a number of debilitating conditions:
'Considering the incredible advancement of psychedelics (most notably, psilocybin) in the health and wellness market, LOVE Pharma's excitement about partnering with a US based pharmaceutical company -developing the technology behind this muco-adhesive strip as a delivery system for psilocybin-is palpable. We recognize the need for discreet, consumer-friendly applications; and with its delivery of consistent dosing, this sublingual strip hits all the marks.' -LOVE Pharma COO, Joshua Maurice
The Company also announces that it has entered into contractual agreements for marketing, communication, shareholder engagement and social media communications. The marketing and communication program will include certain investor relations activities and is designed to provide improved visibility in the Company's current and planned operations. The Company has entered into agreements with Investing News Network for investor awareness services over a 12-month period for $52,200, Ahead of the Herd for marketing and communication program over a 6-month period for $30,000, Digitonic Ltd. for investor awareness services over 6-month period for $216,000, First Phase Media for strategic digital media services, marketing and data analytics services with budget of $121,500, Proactive Investors North America Inc. for investor awareness services over 12-month period for $40,000, Stockwatch for investor awareness services for $11,550, Zastre & Taylor Holdings Inc for investor awareness service for $284,500.
About Love Pharma Inc.
With a focus on the global sexual Health and Wellness markets, Love Pharma Inc. (CSE:LUV)(FSE:G1Q0) was founded in 2020, with a mission to bring to market innovative products that enhance sexual health and wellness while providing an improved quality of life. Love Pharma holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.
For further information, please contact:
Investor Relations
Telephone: 1 (604) 343-2977
E-mail: [email protected]
www.love-pharma.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain statements contained in this release may constitute 'forward-looking statements' or 'forward-looking information' (collectively 'forward-looking information') as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words 'could', 'intend', 'expect', 'believe', 'will', 'projected', 'estimated', 'anticipates' and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
SOURCE: Love Pharma Inc.
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationHAYWARD, California: In a significant step toward its commercial debut, Amazon-owned Zoox has unveiled its first factory dedicated...
SAO PAULO, Brazil: Brazil is taking confident steps to restore its dominance in global poultry exports after declaring its commercial...
NEW YORK, New YorK - U.S. stocks closed mixed on Friday, with gains and losses modest, as investors and traders weighed up the escalation...
WASHINGTON, D.C.: Retail sales dropped sharply in May as consumer spending slowed after a strong start to the year, primarily due to...
WASHINGTON, D.C.: Mitsubishi Motors is the latest automaker to raise prices in the United States, joining a growing list of car companies...
INDIANAPOLIS, Indiana: Eli Lilly is making a bold play in cardiovascular gene therapy, announcing plans to acquire its partner Verve...
Washington [US], June 18 (ANI): R&B singer R Kelly, convicted of racketeering and sex trafficking in 2021, has found himself at the...
ABU DHABI, 16th May, 2025 (WAM) -- Etihad Airways has announced a new addition to its growing US network with the launch of non-stop...
Top adviser Stephen Miller has urgedUS President Donald Trump to take a harsh line on immigration starting with the infamous Muslim...
Prime Minister Benjamin Netanyahu has maintained that preventing Iran from developing a nuclear weapon is the main goal of Israels...
Prime Minister Benjamin Netanyahu has maintained that preventing Iran from developing a nuclear weapon is the main goal of Israels...
WASHINGTON, D.C. - The heart of Washington, D.C., became a landing zone June 14 when an AH-64E Apache helicopter touched down on the...